EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=549474, encodeId=1dbb5494e487, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：速度还行，九月投稿，十月反修，大修，补实验，十一月初投稿，十一月底minor revise，改个小问题就可以了。总的来说还比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf5e102992, createdName=wfbql999, createdTime=Sat Nov 25 10:54:00 CST 2017, time=2017-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839496, encodeId=8256839496ee, content=编辑负责，审稿速度还算可以，大修，按照审稿人的意见修改后，审稿一个月，接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Fri Nov 24 10:19:29 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=837954, encodeId=a91d83e9548e, content=一篇综述，初审3个月，2个审稿人，专业！，编辑给了大修，半个月修回。3天后under review;3天完成审稿，2天后接收。还不知道这个杂志收不收版面费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Tue Aug 22 19:30:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545776, encodeId=5011545e7692, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：最近投了一篇快讯，从投稿到接受发表一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fea01702833, createdName=fox19652ba5, createdTime=Tue Aug 22 14:08:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538505, encodeId=fb8353850575, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：感觉比传闻的要快 2017.3.28 提交初稿 2017.4.20 返回意见大修，两个审稿人，一个只给了些格式等方面的意见，另一个从头到尾把文章说得体无完肤 2017.5.11修回 2017.6.21 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=001e2083602, createdName=zhangli9104_31630911, createdTime=Thu Jun 29 16:31:00 CST 2017, time=2017-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537874, encodeId=082953e87498, content=请问需要收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=783a2075342, createdName=1181547157_70925923, createdTime=Wed Jun 14 20:00:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835293, encodeId=911a8352933b, content=刚刚投稿，还不清楚，想问下，这个杂志社收取出版费用不？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e05414152, createdName=ms2614478266438915, createdTime=Sun Jan 15 10:40:59 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525181, encodeId=9075525181bb, content=审稿都还是比较快的，一个月内搞定，自己动作快点，两个月左右可以见刊。MedSci2 2016-07-24 发表:: 研究方向：药物化学;天然产物改造; 接收率：约75% 审稿时间：约1个月 SCI(2013)：3.4投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, beContent=MedSci2 2016-07-24 发表:: 研究方向：药物化学;天然产物改造; 接收率：约75% 审稿时间：约1个月 SCI(2013)：3.4投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG5794D62DD35395903.jpg, createdBy=05ba1724725, createdName=大智, createdTime=Mon Jul 25 22:40:00 CST 2016, time=2016-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525155, encodeId=af1b52515599, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG5794D62DD35395903.jpg, createdBy=05ba1724725, createdName=大智, createdTime=Sun Jul 24 23:09:00 CST 2016, time=2016-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831272, encodeId=a2a38312e246, content=审稿速度:4.0 经验分享：审稿比较慢，4个月后才回审稿意见，但小修后很快就接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Tue Nov 24 09:25:18 CST 2015, time=2015-11-24, status=1, ipAttribution=)]

2017-11-25 wfbql999

审稿速度:2.0 | 投稿命中率:50.0
经验分享：速度还行，九月投稿，十月反修，大修，补实验，十一月初投稿，十一月底minor revise，改个小问题就可以了。总的来说还比较顺利

399 0

[GetPortalCommentsPageByObjectIdResponse(id=549474, encodeId=1dbb5494e487, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：速度还行，九月投稿，十月反修，大修，补实验，十一月初投稿，十一月底minor revise，改个小问题就可以了。总的来说还比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf5e102992, createdName=wfbql999, createdTime=Sat Nov 25 10:54:00 CST 2017, time=2017-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839496, encodeId=8256839496ee, content=编辑负责，审稿速度还算可以，大修，按照审稿人的意见修改后，审稿一个月，接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Fri Nov 24 10:19:29 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=837954, encodeId=a91d83e9548e, content=一篇综述，初审3个月，2个审稿人，专业！，编辑给了大修，半个月修回。3天后under review;3天完成审稿，2天后接收。还不知道这个杂志收不收版面费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Tue Aug 22 19:30:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545776, encodeId=5011545e7692, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：最近投了一篇快讯，从投稿到接受发表一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fea01702833, createdName=fox19652ba5, createdTime=Tue Aug 22 14:08:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538505, encodeId=fb8353850575, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：感觉比传闻的要快 2017.3.28 提交初稿 2017.4.20 返回意见大修，两个审稿人，一个只给了些格式等方面的意见，另一个从头到尾把文章说得体无完肤 2017.5.11修回 2017.6.21 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=001e2083602, createdName=zhangli9104_31630911, createdTime=Thu Jun 29 16:31:00 CST 2017, time=2017-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537874, encodeId=082953e87498, content=请问需要收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=783a2075342, createdName=1181547157_70925923, createdTime=Wed Jun 14 20:00:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835293, encodeId=911a8352933b, content=刚刚投稿，还不清楚，想问下，这个杂志社收取出版费用不？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e05414152, createdName=ms2614478266438915, createdTime=Sun Jan 15 10:40:59 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525181, encodeId=9075525181bb, content=审稿都还是比较快的，一个月内搞定，自己动作快点，两个月左右可以见刊。MedSci2 2016-07-24 发表:: 研究方向：药物化学;天然产物改造; 接收率：约75% 审稿时间：约1个月 SCI(2013)：3.4投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, beContent=MedSci2 2016-07-24 发表:: 研究方向：药物化学;天然产物改造; 接收率：约75% 审稿时间：约1个月 SCI(2013)：3.4投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG5794D62DD35395903.jpg, createdBy=05ba1724725, createdName=大智, createdTime=Mon Jul 25 22:40:00 CST 2016, time=2016-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525155, encodeId=af1b52515599, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG5794D62DD35395903.jpg, createdBy=05ba1724725, createdName=大智, createdTime=Sun Jul 24 23:09:00 CST 2016, time=2016-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831272, encodeId=a2a38312e246, content=审稿速度:4.0 经验分享：审稿比较慢，4个月后才回审稿意见，但小修后很快就接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Tue Nov 24 09:25:18 CST 2015, time=2015-11-24, status=1, ipAttribution=)]

2017-11-24 ms4729674192825029

编辑负责，审稿速度还算可以，大修，按照审稿人的意见修改后，审稿一个月，接收。

87 0

[GetPortalCommentsPageByObjectIdResponse(id=549474, encodeId=1dbb5494e487, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：速度还行，九月投稿，十月反修，大修，补实验，十一月初投稿，十一月底minor revise，改个小问题就可以了。总的来说还比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf5e102992, createdName=wfbql999, createdTime=Sat Nov 25 10:54:00 CST 2017, time=2017-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839496, encodeId=8256839496ee, content=编辑负责，审稿速度还算可以，大修，按照审稿人的意见修改后，审稿一个月，接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Fri Nov 24 10:19:29 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=837954, encodeId=a91d83e9548e, content=一篇综述，初审3个月，2个审稿人，专业！，编辑给了大修，半个月修回。3天后under review;3天完成审稿，2天后接收。还不知道这个杂志收不收版面费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Tue Aug 22 19:30:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545776, encodeId=5011545e7692, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：最近投了一篇快讯，从投稿到接受发表一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fea01702833, createdName=fox19652ba5, createdTime=Tue Aug 22 14:08:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538505, encodeId=fb8353850575, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：感觉比传闻的要快 2017.3.28 提交初稿 2017.4.20 返回意见大修，两个审稿人，一个只给了些格式等方面的意见，另一个从头到尾把文章说得体无完肤 2017.5.11修回 2017.6.21 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=001e2083602, createdName=zhangli9104_31630911, createdTime=Thu Jun 29 16:31:00 CST 2017, time=2017-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537874, encodeId=082953e87498, content=请问需要收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=783a2075342, createdName=1181547157_70925923, createdTime=Wed Jun 14 20:00:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835293, encodeId=911a8352933b, content=刚刚投稿，还不清楚，想问下，这个杂志社收取出版费用不？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e05414152, createdName=ms2614478266438915, createdTime=Sun Jan 15 10:40:59 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525181, encodeId=9075525181bb, content=审稿都还是比较快的，一个月内搞定，自己动作快点，两个月左右可以见刊。MedSci2 2016-07-24 发表:: 研究方向：药物化学;天然产物改造; 接收率：约75% 审稿时间：约1个月 SCI(2013)：3.4投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, beContent=MedSci2 2016-07-24 发表:: 研究方向：药物化学;天然产物改造; 接收率：约75% 审稿时间：约1个月 SCI(2013)：3.4投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG5794D62DD35395903.jpg, createdBy=05ba1724725, createdName=大智, createdTime=Mon Jul 25 22:40:00 CST 2016, time=2016-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525155, encodeId=af1b52515599, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG5794D62DD35395903.jpg, createdBy=05ba1724725, createdName=大智, createdTime=Sun Jul 24 23:09:00 CST 2016, time=2016-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831272, encodeId=a2a38312e246, content=审稿速度:4.0 经验分享：审稿比较慢，4个月后才回审稿意见，但小修后很快就接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Tue Nov 24 09:25:18 CST 2015, time=2015-11-24, status=1, ipAttribution=)]

2017-08-22 ms4729674192825029

一篇综述，初审3个月，2个审稿人，专业！，编辑给了大修，半个月修回。3天后under review;3天完成审稿，2天后接收。还不知道这个杂志收不收版面费

85 0

[GetPortalCommentsPageByObjectIdResponse(id=549474, encodeId=1dbb5494e487, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：速度还行，九月投稿，十月反修，大修，补实验，十一月初投稿，十一月底minor revise，改个小问题就可以了。总的来说还比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf5e102992, createdName=wfbql999, createdTime=Sat Nov 25 10:54:00 CST 2017, time=2017-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839496, encodeId=8256839496ee, content=编辑负责，审稿速度还算可以，大修，按照审稿人的意见修改后，审稿一个月，接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Fri Nov 24 10:19:29 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=837954, encodeId=a91d83e9548e, content=一篇综述，初审3个月，2个审稿人，专业！，编辑给了大修，半个月修回。3天后under review;3天完成审稿，2天后接收。还不知道这个杂志收不收版面费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Tue Aug 22 19:30:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545776, encodeId=5011545e7692, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：最近投了一篇快讯，从投稿到接受发表一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fea01702833, createdName=fox19652ba5, createdTime=Tue Aug 22 14:08:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538505, encodeId=fb8353850575, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：感觉比传闻的要快 2017.3.28 提交初稿 2017.4.20 返回意见大修，两个审稿人，一个只给了些格式等方面的意见，另一个从头到尾把文章说得体无完肤 2017.5.11修回 2017.6.21 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=001e2083602, createdName=zhangli9104_31630911, createdTime=Thu Jun 29 16:31:00 CST 2017, time=2017-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537874, encodeId=082953e87498, content=请问需要收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=783a2075342, createdName=1181547157_70925923, createdTime=Wed Jun 14 20:00:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835293, encodeId=911a8352933b, content=刚刚投稿，还不清楚，想问下，这个杂志社收取出版费用不？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e05414152, createdName=ms2614478266438915, createdTime=Sun Jan 15 10:40:59 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525181, encodeId=9075525181bb, content=审稿都还是比较快的，一个月内搞定，自己动作快点，两个月左右可以见刊。MedSci2 2016-07-24 发表:: 研究方向：药物化学;天然产物改造; 接收率：约75% 审稿时间：约1个月 SCI(2013)：3.4投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, beContent=MedSci2 2016-07-24 发表:: 研究方向：药物化学;天然产物改造; 接收率：约75% 审稿时间：约1个月 SCI(2013)：3.4投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG5794D62DD35395903.jpg, createdBy=05ba1724725, createdName=大智, createdTime=Mon Jul 25 22:40:00 CST 2016, time=2016-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525155, encodeId=af1b52515599, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG5794D62DD35395903.jpg, createdBy=05ba1724725, createdName=大智, createdTime=Sun Jul 24 23:09:00 CST 2016, time=2016-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831272, encodeId=a2a38312e246, content=审稿速度:4.0 经验分享：审稿比较慢，4个月后才回审稿意见，但小修后很快就接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Tue Nov 24 09:25:18 CST 2015, time=2015-11-24, status=1, ipAttribution=)]

2017-08-22 fox19652ba5

审稿速度:1.0 | 投稿命中率:50.0
经验分享：最近投了一篇快讯，从投稿到接受发表一个月。

435 0

[GetPortalCommentsPageByObjectIdResponse(id=549474, encodeId=1dbb5494e487, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：速度还行，九月投稿，十月反修，大修，补实验，十一月初投稿，十一月底minor revise，改个小问题就可以了。总的来说还比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf5e102992, createdName=wfbql999, createdTime=Sat Nov 25 10:54:00 CST 2017, time=2017-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839496, encodeId=8256839496ee, content=编辑负责，审稿速度还算可以，大修，按照审稿人的意见修改后，审稿一个月，接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Fri Nov 24 10:19:29 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=837954, encodeId=a91d83e9548e, content=一篇综述，初审3个月，2个审稿人，专业！，编辑给了大修，半个月修回。3天后under review;3天完成审稿，2天后接收。还不知道这个杂志收不收版面费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Tue Aug 22 19:30:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545776, encodeId=5011545e7692, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：最近投了一篇快讯，从投稿到接受发表一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fea01702833, createdName=fox19652ba5, createdTime=Tue Aug 22 14:08:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538505, encodeId=fb8353850575, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：感觉比传闻的要快 2017.3.28 提交初稿 2017.4.20 返回意见大修，两个审稿人，一个只给了些格式等方面的意见，另一个从头到尾把文章说得体无完肤 2017.5.11修回 2017.6.21 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=001e2083602, createdName=zhangli9104_31630911, createdTime=Thu Jun 29 16:31:00 CST 2017, time=2017-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537874, encodeId=082953e87498, content=请问需要收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=783a2075342, createdName=1181547157_70925923, createdTime=Wed Jun 14 20:00:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835293, encodeId=911a8352933b, content=刚刚投稿，还不清楚，想问下，这个杂志社收取出版费用不？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e05414152, createdName=ms2614478266438915, createdTime=Sun Jan 15 10:40:59 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525181, encodeId=9075525181bb, content=审稿都还是比较快的，一个月内搞定，自己动作快点，两个月左右可以见刊。MedSci2 2016-07-24 发表:: 研究方向：药物化学;天然产物改造; 接收率：约75% 审稿时间：约1个月 SCI(2013)：3.4投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, beContent=MedSci2 2016-07-24 发表:: 研究方向：药物化学;天然产物改造; 接收率：约75% 审稿时间：约1个月 SCI(2013)：3.4投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG5794D62DD35395903.jpg, createdBy=05ba1724725, createdName=大智, createdTime=Mon Jul 25 22:40:00 CST 2016, time=2016-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525155, encodeId=af1b52515599, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG5794D62DD35395903.jpg, createdBy=05ba1724725, createdName=大智, createdTime=Sun Jul 24 23:09:00 CST 2016, time=2016-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831272, encodeId=a2a38312e246, content=审稿速度:4.0 经验分享：审稿比较慢，4个月后才回审稿意见，但小修后很快就接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Tue Nov 24 09:25:18 CST 2015, time=2015-11-24, status=1, ipAttribution=)]

2017-06-29 zhangli9104_31630911

审稿速度:1.0 | 投稿命中率:75.0
经验分享：感觉比传闻的要快
2017.3.28 提交初稿
2017.4.20 返回意见大修，两个审稿人，一个只给了些格式等方面的意见，另一个从头到尾把文章说得体无完肤
2017.5.11修回
2017.6.21 接收

399 0

[GetPortalCommentsPageByObjectIdResponse(id=549474, encodeId=1dbb5494e487, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：速度还行，九月投稿，十月反修，大修，补实验，十一月初投稿，十一月底minor revise，改个小问题就可以了。总的来说还比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf5e102992, createdName=wfbql999, createdTime=Sat Nov 25 10:54:00 CST 2017, time=2017-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839496, encodeId=8256839496ee, content=编辑负责，审稿速度还算可以，大修，按照审稿人的意见修改后，审稿一个月，接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Fri Nov 24 10:19:29 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=837954, encodeId=a91d83e9548e, content=一篇综述，初审3个月，2个审稿人，专业！，编辑给了大修，半个月修回。3天后under review;3天完成审稿，2天后接收。还不知道这个杂志收不收版面费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Tue Aug 22 19:30:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545776, encodeId=5011545e7692, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：最近投了一篇快讯，从投稿到接受发表一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fea01702833, createdName=fox19652ba5, createdTime=Tue Aug 22 14:08:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538505, encodeId=fb8353850575, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：感觉比传闻的要快 2017.3.28 提交初稿 2017.4.20 返回意见大修，两个审稿人，一个只给了些格式等方面的意见，另一个从头到尾把文章说得体无完肤 2017.5.11修回 2017.6.21 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=001e2083602, createdName=zhangli9104_31630911, createdTime=Thu Jun 29 16:31:00 CST 2017, time=2017-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537874, encodeId=082953e87498, content=请问需要收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=783a2075342, createdName=1181547157_70925923, createdTime=Wed Jun 14 20:00:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835293, encodeId=911a8352933b, content=刚刚投稿，还不清楚，想问下，这个杂志社收取出版费用不？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e05414152, createdName=ms2614478266438915, createdTime=Sun Jan 15 10:40:59 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525181, encodeId=9075525181bb, content=审稿都还是比较快的，一个月内搞定，自己动作快点，两个月左右可以见刊。MedSci2 2016-07-24 发表:: 研究方向：药物化学;天然产物改造; 接收率：约75% 审稿时间：约1个月 SCI(2013)：3.4投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, beContent=MedSci2 2016-07-24 发表:: 研究方向：药物化学;天然产物改造; 接收率：约75% 审稿时间：约1个月 SCI(2013)：3.4投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG5794D62DD35395903.jpg, createdBy=05ba1724725, createdName=大智, createdTime=Mon Jul 25 22:40:00 CST 2016, time=2016-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525155, encodeId=af1b52515599, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG5794D62DD35395903.jpg, createdBy=05ba1724725, createdName=大智, createdTime=Sun Jul 24 23:09:00 CST 2016, time=2016-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831272, encodeId=a2a38312e246, content=审稿速度:4.0 经验分享：审稿比较慢，4个月后才回审稿意见，但小修后很快就接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Tue Nov 24 09:25:18 CST 2015, time=2015-11-24, status=1, ipAttribution=)]

2017-06-14 1181547157_70925923

请问需要收版面费吗

556 0

[GetPortalCommentsPageByObjectIdResponse(id=549474, encodeId=1dbb5494e487, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：速度还行，九月投稿，十月反修，大修，补实验，十一月初投稿，十一月底minor revise，改个小问题就可以了。总的来说还比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf5e102992, createdName=wfbql999, createdTime=Sat Nov 25 10:54:00 CST 2017, time=2017-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839496, encodeId=8256839496ee, content=编辑负责，审稿速度还算可以，大修，按照审稿人的意见修改后，审稿一个月，接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Fri Nov 24 10:19:29 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=837954, encodeId=a91d83e9548e, content=一篇综述，初审3个月，2个审稿人，专业！，编辑给了大修，半个月修回。3天后under review;3天完成审稿，2天后接收。还不知道这个杂志收不收版面费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Tue Aug 22 19:30:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545776, encodeId=5011545e7692, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：最近投了一篇快讯，从投稿到接受发表一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fea01702833, createdName=fox19652ba5, createdTime=Tue Aug 22 14:08:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538505, encodeId=fb8353850575, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：感觉比传闻的要快 2017.3.28 提交初稿 2017.4.20 返回意见大修，两个审稿人，一个只给了些格式等方面的意见，另一个从头到尾把文章说得体无完肤 2017.5.11修回 2017.6.21 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=001e2083602, createdName=zhangli9104_31630911, createdTime=Thu Jun 29 16:31:00 CST 2017, time=2017-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537874, encodeId=082953e87498, content=请问需要收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=783a2075342, createdName=1181547157_70925923, createdTime=Wed Jun 14 20:00:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835293, encodeId=911a8352933b, content=刚刚投稿，还不清楚，想问下，这个杂志社收取出版费用不？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e05414152, createdName=ms2614478266438915, createdTime=Sun Jan 15 10:40:59 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525181, encodeId=9075525181bb, content=审稿都还是比较快的，一个月内搞定，自己动作快点，两个月左右可以见刊。MedSci2 2016-07-24 发表:: 研究方向：药物化学;天然产物改造; 接收率：约75% 审稿时间：约1个月 SCI(2013)：3.4投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, beContent=MedSci2 2016-07-24 发表:: 研究方向：药物化学;天然产物改造; 接收率：约75% 审稿时间：约1个月 SCI(2013)：3.4投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG5794D62DD35395903.jpg, createdBy=05ba1724725, createdName=大智, createdTime=Mon Jul 25 22:40:00 CST 2016, time=2016-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525155, encodeId=af1b52515599, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG5794D62DD35395903.jpg, createdBy=05ba1724725, createdName=大智, createdTime=Sun Jul 24 23:09:00 CST 2016, time=2016-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831272, encodeId=a2a38312e246, content=审稿速度:4.0 经验分享：审稿比较慢，4个月后才回审稿意见，但小修后很快就接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Tue Nov 24 09:25:18 CST 2015, time=2015-11-24, status=1, ipAttribution=)]

2017-01-15 ms2614478266438915

刚刚投稿，还不清楚，想问下，这个杂志社收取出版费用不？

39 0

[GetPortalCommentsPageByObjectIdResponse(id=549474, encodeId=1dbb5494e487, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：速度还行，九月投稿，十月反修，大修，补实验，十一月初投稿，十一月底minor revise，改个小问题就可以了。总的来说还比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf5e102992, createdName=wfbql999, createdTime=Sat Nov 25 10:54:00 CST 2017, time=2017-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839496, encodeId=8256839496ee, content=编辑负责，审稿速度还算可以，大修，按照审稿人的意见修改后，审稿一个月，接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Fri Nov 24 10:19:29 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=837954, encodeId=a91d83e9548e, content=一篇综述，初审3个月，2个审稿人，专业！，编辑给了大修，半个月修回。3天后under review;3天完成审稿，2天后接收。还不知道这个杂志收不收版面费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Tue Aug 22 19:30:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545776, encodeId=5011545e7692, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：最近投了一篇快讯，从投稿到接受发表一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fea01702833, createdName=fox19652ba5, createdTime=Tue Aug 22 14:08:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538505, encodeId=fb8353850575, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：感觉比传闻的要快 2017.3.28 提交初稿 2017.4.20 返回意见大修，两个审稿人，一个只给了些格式等方面的意见，另一个从头到尾把文章说得体无完肤 2017.5.11修回 2017.6.21 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=001e2083602, createdName=zhangli9104_31630911, createdTime=Thu Jun 29 16:31:00 CST 2017, time=2017-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537874, encodeId=082953e87498, content=请问需要收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=783a2075342, createdName=1181547157_70925923, createdTime=Wed Jun 14 20:00:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835293, encodeId=911a8352933b, content=刚刚投稿，还不清楚，想问下，这个杂志社收取出版费用不？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e05414152, createdName=ms2614478266438915, createdTime=Sun Jan 15 10:40:59 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525181, encodeId=9075525181bb, content=审稿都还是比较快的，一个月内搞定，自己动作快点，两个月左右可以见刊。MedSci2 2016-07-24 发表:: 研究方向：药物化学;天然产物改造; 接收率：约75% 审稿时间：约1个月 SCI(2013)：3.4投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, beContent=MedSci2 2016-07-24 发表:: 研究方向：药物化学;天然产物改造; 接收率：约75% 审稿时间：约1个月 SCI(2013)：3.4投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG5794D62DD35395903.jpg, createdBy=05ba1724725, createdName=大智, createdTime=Mon Jul 25 22:40:00 CST 2016, time=2016-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525155, encodeId=af1b52515599, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG5794D62DD35395903.jpg, createdBy=05ba1724725, createdName=大智, createdTime=Sun Jul 24 23:09:00 CST 2016, time=2016-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831272, encodeId=a2a38312e246, content=审稿速度:4.0 经验分享：审稿比较慢，4个月后才回审稿意见，但小修后很快就接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Tue Nov 24 09:25:18 CST 2015, time=2015-11-24, status=1, ipAttribution=)]

2016-07-25 大智

审稿都还是比较快的，一个月内搞定，自己动作快点，两个月左右可以见刊。MedSci2 2016-07-24 发表::
研究方向：药物化学;天然产物改造; 接收率：约75% 审稿时间：约1个月 SCI(2013)：3.4投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。

MedSci2 2016-07-24 发表:: 研究方向：药物化学;天然产物改造; 接收率：约75% 审稿时间：约1个月 SCI(2013)：3.4投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。

383 0

[GetPortalCommentsPageByObjectIdResponse(id=549474, encodeId=1dbb5494e487, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：速度还行，九月投稿，十月反修，大修，补实验，十一月初投稿，十一月底minor revise，改个小问题就可以了。总的来说还比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf5e102992, createdName=wfbql999, createdTime=Sat Nov 25 10:54:00 CST 2017, time=2017-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839496, encodeId=8256839496ee, content=编辑负责，审稿速度还算可以，大修，按照审稿人的意见修改后，审稿一个月，接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Fri Nov 24 10:19:29 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=837954, encodeId=a91d83e9548e, content=一篇综述，初审3个月，2个审稿人，专业！，编辑给了大修，半个月修回。3天后under review;3天完成审稿，2天后接收。还不知道这个杂志收不收版面费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Tue Aug 22 19:30:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545776, encodeId=5011545e7692, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：最近投了一篇快讯，从投稿到接受发表一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fea01702833, createdName=fox19652ba5, createdTime=Tue Aug 22 14:08:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538505, encodeId=fb8353850575, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：感觉比传闻的要快 2017.3.28 提交初稿 2017.4.20 返回意见大修，两个审稿人，一个只给了些格式等方面的意见，另一个从头到尾把文章说得体无完肤 2017.5.11修回 2017.6.21 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=001e2083602, createdName=zhangli9104_31630911, createdTime=Thu Jun 29 16:31:00 CST 2017, time=2017-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537874, encodeId=082953e87498, content=请问需要收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=783a2075342, createdName=1181547157_70925923, createdTime=Wed Jun 14 20:00:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835293, encodeId=911a8352933b, content=刚刚投稿，还不清楚，想问下，这个杂志社收取出版费用不？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e05414152, createdName=ms2614478266438915, createdTime=Sun Jan 15 10:40:59 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525181, encodeId=9075525181bb, content=审稿都还是比较快的，一个月内搞定，自己动作快点，两个月左右可以见刊。MedSci2 2016-07-24 发表:: 研究方向：药物化学;天然产物改造; 接收率：约75% 审稿时间：约1个月 SCI(2013)：3.4投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, beContent=MedSci2 2016-07-24 发表:: 研究方向：药物化学;天然产物改造; 接收率：约75% 审稿时间：约1个月 SCI(2013)：3.4投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG5794D62DD35395903.jpg, createdBy=05ba1724725, createdName=大智, createdTime=Mon Jul 25 22:40:00 CST 2016, time=2016-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525155, encodeId=af1b52515599, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG5794D62DD35395903.jpg, createdBy=05ba1724725, createdName=大智, createdTime=Sun Jul 24 23:09:00 CST 2016, time=2016-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831272, encodeId=a2a38312e246, content=审稿速度:4.0 经验分享：审稿比较慢，4个月后才回审稿意见，但小修后很快就接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Tue Nov 24 09:25:18 CST 2015, time=2015-11-24, status=1, ipAttribution=)]

2016-07-24 大智

审稿速度:1.0 | 投稿命中率:75.0
经验分享：投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。

383 0

[GetPortalCommentsPageByObjectIdResponse(id=549474, encodeId=1dbb5494e487, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：速度还行，九月投稿，十月反修，大修，补实验，十一月初投稿，十一月底minor revise，改个小问题就可以了。总的来说还比较顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf5e102992, createdName=wfbql999, createdTime=Sat Nov 25 10:54:00 CST 2017, time=2017-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=839496, encodeId=8256839496ee, content=编辑负责，审稿速度还算可以，大修，按照审稿人的意见修改后，审稿一个月，接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Fri Nov 24 10:19:29 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=837954, encodeId=a91d83e9548e, content=一篇综述，初审3个月，2个审稿人，专业！，编辑给了大修，半个月修回。3天后under review;3天完成审稿，2天后接收。还不知道这个杂志收不收版面费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Tue Aug 22 19:30:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545776, encodeId=5011545e7692, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：最近投了一篇快讯，从投稿到接受发表一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fea01702833, createdName=fox19652ba5, createdTime=Tue Aug 22 14:08:00 CST 2017, time=2017-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538505, encodeId=fb8353850575, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：感觉比传闻的要快 2017.3.28 提交初稿 2017.4.20 返回意见大修，两个审稿人，一个只给了些格式等方面的意见，另一个从头到尾把文章说得体无完肤 2017.5.11修回 2017.6.21 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=399, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=001e2083602, createdName=zhangli9104_31630911, createdTime=Thu Jun 29 16:31:00 CST 2017, time=2017-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537874, encodeId=082953e87498, content=请问需要收版面费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=783a2075342, createdName=1181547157_70925923, createdTime=Wed Jun 14 20:00:00 CST 2017, time=2017-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835293, encodeId=911a8352933b, content=刚刚投稿，还不清楚，想问下，这个杂志社收取出版费用不？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6e05414152, createdName=ms2614478266438915, createdTime=Sun Jan 15 10:40:59 CST 2017, time=2017-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525181, encodeId=9075525181bb, content=审稿都还是比较快的，一个月内搞定，自己动作快点，两个月左右可以见刊。MedSci2 2016-07-24 发表:: 研究方向：药物化学;天然产物改造; 接收率：约75% 审稿时间：约1个月 SCI(2013)：3.4投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, beContent=MedSci2 2016-07-24 发表:: 研究方向：药物化学;天然产物改造; 接收率：约75% 审稿时间：约1个月 SCI(2013)：3.4投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG5794D62DD35395903.jpg, createdBy=05ba1724725, createdName=大智, createdTime=Mon Jul 25 22:40:00 CST 2016, time=2016-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525155, encodeId=af1b52515599, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：投稿7次，中了6次，其中一篇邀稿综述，一般都是小修即可接受。本人做天然产物结构改造优化的，医药和农药均有涉及。貌似跟Herve Galons Editor-in-Chief关系不错，还邀请审稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160724/IMG5794D62DD35395903.jpg, createdBy=05ba1724725, createdName=大智, createdTime=Sun Jul 24 23:09:00 CST 2016, time=2016-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831272, encodeId=a2a38312e246, content=审稿速度:4.0 经验分享：审稿比较慢，4个月后才回审稿意见，但小修后很快就接受了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7555414117, createdName=ms61234328952836, createdTime=Tue Nov 24 09:25:18 CST 2015, time=2015-11-24, status=1, ipAttribution=)]

2015-11-24 ms61234328952836

审稿速度:4.0
经验分享：审稿比较慢，4个月后才回审稿意见，但小修后很快就接受了。

96 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务